ACT CAPITAL MANAGEMENT, LLC - Q3 2022 holdings

$72.5 Million is the total value of ACT CAPITAL MANAGEMENT, LLC's 71 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .

 Value Shares↓ Weighting
MOGO ExitMOGO INC$0-19,491
-100.0%
-0.02%
KERN ExitAKERNA CORP$0-128,000
-100.0%
-0.02%
ExitLOTTERY COM INC*w exp 05/09/202$0-125,000
-100.0%
-0.04%
SYRS ExitSYROS PHARMACEUTICALS INC$0-35,000
-100.0%
-0.05%
HSDT ExitHELIUS MED TECHNOLOGIES INC$0-35,263
-100.0%
-0.06%
AMPE ExitAMPIO PHARMACEUTICALS INC$0-291,500
-100.0%
-0.07%
ExitLOTTERY COM INC$0-56,000
-100.0%
-0.09%
CLRB ExitCELLECTAR BIOSCIENCES INC$0-217,500
-100.0%
-0.12%
IMTX ExitIMMATICS N V$0-10,300
-100.0%
-0.13%
AUD ExitAUDACY INCcl a$0-97,500
-100.0%
-0.13%
AMZN ExitAMAZON.COM INC$0-1,000
-100.0%
-0.15%
RYTM ExitRHYTHM PHARMACEUTICALS INC$0-27,500
-100.0%
-0.16%
LTHM ExitLIVENT CORP$0-6,000
-100.0%
-0.19%
NTRA ExitNATERA INC$0-7,000
-100.0%
-0.35%
AUPH ExitAURINIA PHARMACEUTICALS INC$0-51,000
-100.0%
-0.72%
MRVI ExitMARAVAI LIFESCIENCES HLDGS INC$0-24,500
-100.0%
-0.97%
CF ExitCF INDUSTRIES HOLDINGS INC$0-9,000
-100.0%
-1.08%
LNTH ExitLANTHEUS HOLDINGS INC$0-12,900
-100.0%
-1.19%
IDYA ExitIDEAYA BIOSCIENCES INC$0-173,500
-100.0%
-3.35%
ADTN ExitADTRAN INC$0-150,000
-100.0%
-3.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO6Q3 202222.7%
ARROWHEAD PHARMACEUTICALS INC6Q3 202210.1%
ARCTURUS THERAPEUTICS HLDGS6Q3 202212.8%
CLEARSIDE BIOMEDICAL INC6Q3 20227.7%
KRYSTAL BIOTECH INC6Q3 20225.6%
FUBOTV INC6Q3 20224.4%
EIGER BIOPHARMACEUTICALS INC6Q3 20222.4%
ASPIRA WOMENS HEALTH INC6Q3 20223.3%
ICAD INC6Q3 20222.0%
INHIBIKASE THERAPEUTICS INC COM6Q3 20221.7%

View ACT CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ACT CAPITAL MANAGEMENT, LLC Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HyreCar Inc.December 09, 2020230,0001.3%
SOLIGENIX, INC.February 07, 20201,221,4995.6%
EDISON NATION, INC.April 18, 2019214,4543.8%
Hancock Jaffe Laboratories, Inc.December 26, 2018503,5004.3%
Ampio Pharmaceuticals, Inc.August 10, 20181,210,7851.4%
Xspand Products Lab, Inc.May 09, 2018405,0009.3%
CROSSROADS SYSTEMS INCJune 16, 201759,0534.8%
ALLDIGITAL HOLDINGS, INC.Sold outJanuary 23, 201700.0%
MOBIVITY HOLDINGS CORP.January 06, 20171,734,9164.8%
Akers Biosciences IncJanuary 25, 2016213,5003.9%

View ACT CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2022-11-03
13F-HR2022-08-12
13F-HR2022-05-11
13F-HR2022-02-03
13F-HR2021-11-16
13F-HR2021-08-16
SC 13G/A2020-12-09
SC 13G/A2020-02-10
SC 13G/A2020-02-07
SC 13G/A2020-02-07

View ACT CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export ACT CAPITAL MANAGEMENT, LLC's holdings